2021 Annual Meeting Awards Ceremony

ASIPP held its 2021 Annual Meeting Award Ceremony on Friday, June 25 at the ASIPP 23rd Annual Meeting in New Orleans.

Award recipients and participants are (from right to left): Harold Cordner, MD – League of Presidents; Devi Nampiaparampil, MD, Session Chair; Nebojsa Nick Knezevic, MD, PhD – Manchikanti Excellence Award; Kenneth Candido, MD – Racz Excellence Award; Gabor Racz, MD; Laxmaiah Manchikanti, MD, Chairman of the Board and CEO, ASIPP; Amol Soin, MD, President, ASIPP; John Swicegood, MD – Lifetime Achievement Award; David Schultz, MD – Lifetime Achievement Award

Recorded versions of our virtual review courses are available to purchase. The following courses are offered:

Attendees Price
New Registration
Imaging Review Course$ 100$ 300
Controlled Substance Management$ 100$ 300
Documentation, Coding, Compliance, and Practice Management$ 100$ 300
Board Review Course$ 200$ 500


Aug 20-22, 2021Ohio and Kentucky Societies of Interventional Pain Physicians Annual MeetingThe Westin Cincinnati
21 E 5th Street
Cincinnati, OH 45202
September 18, 2021Kansas Society of Interventional Pain Physicians 2021 MeetingThe InterContinental Kansas City at the Plaza
401 Ward Parkway
Kansas City, MO 64112
Oct 15-17, 2021California Society of Interventional Pain Physicians Annual MeetingTerranea
100 Terranea Way
Rancho Palos Verdes, CA 90275

Click here to see more upcoming state society meetings!


Here are some of the available ASIPP® Podcasts:

  • Dr. Amol Soin And The Business Side Of COVID-19
  • Dr. Kevin Pho of Reveals Terrific Insight And Ideas On The “New Norm” After The COVID-19
  • Andrea Trescot, MD Takes On The Subject Of Controlled Substance Management
  • ASIPP® Pod August 2019 – Distinguished Pain Leaders Prunskis, Prunskis, and Helm Discuss Issues That Face IPM
  • Miles Day Of Texas Tech Discusses Multiple Pain Management Topics



Join ASIPP. Your Voice For Interventional Pain Management

On July 19, 2021, the Centers for Medicare and Medicaid Services proposed Medicare Payment rates for hospital outpatient department and ambulatory surgical center services. The good news is that the updates for ASCs is similar to HOPDs. The bad news is several procedures, which were covered in ASCs are eliminated and changed to the inpatient only list. The ugly news is an addition of 6% cuts, 2% stemming from sequester cuts of the Budget Control Act of 2011 and 4% statutory PAYGO sequester resulting from passage of the American Rescue Plan Act lasting 10 years, totaling 6%. Read more on proposed fee rule for HOPDs and ASCs.


On July 13, 2021, CMS issued a proposed rule updating payment policies and rates for physicians paid under the Medicare Physician fee schedule in 2022. The proposed rule illustrates includes a 9.75% cut in the reimbursement rates from 2021. This affects interventional pain physicians, along with the entire physician and provider community.


ASIPP Writes Comment Letters on Proposed LCD on Epidural Procedures for Pain Management Services

A proposed LCD on Epidural Procedures for Pain Management services was announced on June 10, 2021. This nationwide policy contains many onerous changes that will detrimentally affect patient access to care. ASIPP has written comment letters with detailed explanations of the issues and needed changes to each Medicare Contractor. The following are examples of the ASIPP comment letters:

ASIPP Fact Sheet on Epidural Procedures for Pain Management
ASIPP General Comment Letter to CMS Coverage Policy Analysis Group
Letter to Tamara Syrek Jensen, MD; Andrew Ward, PhD, MPH; Melissa A. Evans, PhD, MSAE; Elizabeth Truong, MD
CGS Letter on Epidural LCD
First Coast Epidural LCD Letter
Palmetto Epidural LCD Letter
WPS Epidural LCD Letter
NGS Epidural LCD Letter
Novitas Epidural LCD Letter

CAC Presentations – Dr.  Laxmaiah Manchikanti and Dr. Amol Soin

ASIPP Resources for COVID-19 and Your Practice

Click here to access ASIPP’s COVID-19 Resources. Here is a list of some of the articles found there:
1. ASIPP Draft Guidance Document on COVID-19 Vaccine and Steroids

2. Good News About Telehealth and Payroll Protection Program

ASIPP Sends Letter to United Healthcare on Latest Policy on Epidural Steroid Injections for Spinal Pain

ASIPP has been working since the beginning of 2021 to improve United HealthCare’s policy on epidural steroid injections for spinal pain. While they have made some positive revisions, some issues still remain, and we have new concerns with their revised policy. 

See ASIPP’s letters and United Healthcare’s response.

Audits of Medicare Payments for Spinal Pain Management Services

Medicare Part B covers various spinal pain management services including facet joint injections, facet joint denervation sessions, lumbar epidural injections, and trigger point injections. Medicare Part B also covers sedation administered during these pain management services. We will audit whether Medicare payments for spinal pain management services billed by physicians complied with Federal requirements. Expected Issue Date (FY) 2022

Click here for more information and related articles.

New Nationwide Policy on Facet Joint Interventions!

Interventional pain management techniques in general, facet joint interventions, and epidural interventions in particular, have been in the news for the past year. There have been 2 reports from the Office of Inspector General (OIG) covering the frequency of therapeutic facet joint injections and another report from Noridian with only 49% of the claims meeting appropriateness criteria.

Based on the Cures Act to provide uniformity and transparency, new local coverage determinations (LCDs) have been established. Consequently, a multijurisdictional expert committee had hearings on potential coverages on the future for facet joint interventions in May 2020 and for epidural interventions in February 2021.



ASIPP is pleased to announce the publication of the Comprehensive Evidence-Based Guidelines for Epidural Interventions in the Management of Chronic Spinal Pain. In preparation of the guidelines, an extensive literature review was performed. The 210-page guidelines contains 33 figures, 48 tables, 1,345 references and has 60 authors.

In addition to the review of multiple manuscripts in reference to utilization, expenditures, anatomical and pathophysiological considerations, pharmacological and harmful effects of drugs and procedures, for evidence synthesis, we have included 47 systematic reviews and 43 RCTs covering all epidural.


Final rule gives providers access to patient treatment histories, and streamlines prior authorization to improve patient experience and alleviate burden for health care providers.


Placebo effect is fascinating, yet totally misunderstood and biased. A placebo is a substance or treatment, which is designed to have no therapeutic value. Essentially, it means an inert substance is injected into an inert structure through injection other than by mouth or sham surgery. The use of placebos in clinical medicine raises ethical concerns, especially if they are disguised as an active treatment, as this introduces dishonesty into the doctor-patient relationship and bypasses informed consent.


ASIPP announces process to claim third-round stimulus checks and extends support for COVID-19 Relief Legislation, advancing essential policies supporting patients and physicians


ASIPP this week sent seven comment letters to the following insurance providers regarding proposed rules that would hinder access of facet joint injections to patients. Click on the links below to read each letter.

CGS Administrators, LLC
First Coast Service Options, Inc.
National Government Services
Novitas Solutions, Inc.
Noridian Healthcare Solutions, LLC
Palmetto, GBA
Wisconsin Physician Services Insurance Corporation

Amniotic Tissue Intraarticular Injections

Many ASIPP members have recently been approached by sales representatives claiming that amniotic or umbilical cord tissue products are now covered by Medicare and many private insurers for intraarticular injections and interventional pain management procedures.

Based on collective evidence, unfortunately, these claims appear to be INACCURATE, subjecting patients and providers to high risk.

Amnion is covered for limited cutaneous wound healing applications and for a handful of neurosurgical and ophthalmic surgical uses, it has a product reimbursement code (also known as a Q code). If a physician submits the right combination of ICD-10 and CPT codes, Medicare may pay these claims.

Based on review of Medicare local coverage determination (LCD) documents, biologics for intraarticular injections and interventional pain management procedures are Experimental and Investigational. Hence, there is NO coverage for these products for intraarticular injections and interventional pain management procedures. 

It’s the recommendation of ASIPP that you avoid billing Medicare and private insurance for these products when used to treat orthopedic and pain management conditions. Our concern is that by billing these products to a federal program like Medicare, not only could there be significant Medicare clawbacks, but knowingly billing Medicare for products that you know are not covered can result in serious criminal penalties. Even, initial losses could be extensive.

For additional information on coverage guidelines from many private insurers that state that these products are NOT covered, experimental and investigational. Please check the websites of commercial carriers.

As you know, ASIPP has been in the forefront and continuing our advocacy to make telehealth permanent for all insurers and all payers. In addition, we have also been trying to keep telephone only at the same price as face-to-face or telehealth visits…

On behalf of ASIPP, we would like to remind members of additional financing, SBA disaster loan options, and the Employee Retention Credit Programs designed for economic relief for practices/businesses suffering economic losses from Covid-19. For those who may feel the PPP Loans/Medicare Advanced Payments are not enough to fund operations through the crisis, there is another SBA program that could help you.


There have been numerous changes since the CDC guidelines were first published. During this time, HHS Inter-Agency Task Force developed Pain Management Best Practices: Updates, Gaps, Inconsistencies, and Recommendations. This is an excellent document with significant importance to interventional pain management.


Manchikanti and 37 distinguished co-authors from multiple institutions have published “Comprehensive Evidence-based Guidelines for Facet Joint Interventions in Management of Chronic Spinal Pain


The following is important information on the newly released 2020 payment rules. ASIPP and SIPMS will be sending comment letters to CMS in the near future. You may also send comment letters to them on these payment rules.



ASIPP Annouces ASIPP Store to Help Provide Value to Your Practice

We are pleased to offer a new feature for our members to help provide value to you and your practice. Please visit our newly created site where you can make purchases on our Amazon Store, learn more about and join the ASIPP GPO and ASIPP’s partnership with Fedora Billing & Revenue Cycle Management Company.

Doctor Finder allows you to search for an ASIPP® Member Interventional Pain Physician anywhere in America by name or by location. It’s quick and easy.

PainExam is proud to announce that it now offers preparation for the ABIPP Pain Management Board Exam! In addition, PainExam has now collaborated with ASIPP to offer Virtual Learning programs.


PainCast, the pain management network, has collected years worth of information on the history and processes of the pain management specialization and transformed it into a virtual library of videos, journals, articles, podcasts, and more – all at your fingertips.

Essentials of Regenerative Medicine in Interventional Pain Management is a book to bring concise, collective, and comprehensive information to interventional pain physicians practicing regenerative medicine with its applications in managing chronic pain.


ASIPP has formed a partnership with Henry Schein and PedsPal, a national GPO that has a successful history of negotiating better prices on medical supplies and creating value added services for the independent physician.


The American Society of Interventional Pain Physicians (ASIPP) is pleased to announce a partnership with Willow Risk Advisors to create an exclusive policy available to ASIPP members. In an effort to further increase value to its physician members, the American Society of Interventional Pain Physicians (ASIPP) has endorsed Willow Risk Advisors as their professional liability insurance broker.


ASIPP is now offering our members the benefit of a unique revenue cycle management/billing service. We have received a tremendous amount of interest in the ASIPP billing and coding program.